6 months ago
KYMR
AnalystsSudan LoganathanSudan Loganathan's Stock Forecasts
AnalystsSudan Loganathan
Sectors:
Industries:
Analyst Ranking
Top 13%
#678 out of 5502 analysts
Average Return
+21.42%
Win Rate
67%33 out of 49
Risk vs Reward
Poor
Good
Sudan Loganathan's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Adc Therapeutics SaADCT | +175.63% | $1.60 | $4.41 | 2025-02-24 - 2026-02-23 | Strong Buy |
Candel Therapeutics IncCADL | +142.20% | $5.45 | $13.20 | 2025-12-08 - 2026-09-02 | Strong Buy |
Immunome IncIMNM | +140.53% | $8.66 | $20.83 | 2025-03-20 - 2026-03-19 | Strong Buy |
Candel Therapeutics IncCADL | +135.71% | $5.60 | $13.20 | 2025-10-28 - 2026-09-02 | Strong Buy |
Delcath Systems IncDCTH | +116.27% | $7.07 | $15.29 | 2024-05-14 - 2025-05-13 | Strong Buy |
Sudan Loganathan Analyst Color
Get additional color on Sudan Loganathan's coverage of popular stocks
9 months ago
KYMR
9 months ago
PYXS
Sudan Loganathan's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Arvinas IncARVN | 4 | Strong Buy | $18.00 | +87.70% | Reiterates | 3 months ago |
Palvella Therapeutics IncPVLA | 2 | Strong Buy | $220.00 | +43.84% | Reiterates | 3 months ago |
Catalyst Pharmaceuticals IncCPRX | 3 | Hold | N/A | N/A | Downgrades | 4 months ago |
Actinium Pharmaceuticals IncATNM | 3 | Strong Buy | $5.00 | +400.00% | Reiterates | 5 months ago |
Immunome IncIMNM | 4 | Strong Buy | $30.00 | +9.77% | Maintains | 6 months ago |
Kymera Therapeutics IncKYMR | 4 | Strong Buy | $100.00 | -15.70% | Maintains | 6 months ago |
Apogee Therapeutics IncAPGE | 1 | Strong Buy | $95.00 | -29.67% | Initiates Coverage On | 9 months ago |
Candel Therapeutics IncCADL | 2 | Strong Buy | $15.00 | +13.64% | Reiterates | 9 months ago |
Pyxis Oncology IncPYXS | 2 | Strong Buy | $8.00 | +113.33% | Maintains | 9 months ago |
Delcath Systems IncDCTH | 4 | Strong Buy | $18.00 | +8.56% | Maintains | 10 months ago |
Centessa Pharmaceuticals PLCCNTA | 1 | Strong Buy | $35.00 | -13.58% | Initiates Coverage On | 10 months ago |
C4 Therapeutics IncCCCC | 3 | Strong Buy | $6.00 | +58.31% | Reiterates | a year ago |
Ideaya Biosciences IncIDYA | 3 | Strong Buy | $45.00 | +12.02% | Reiterates | a year ago |
Nurix Therapeutics IncNRIX | 4 | Strong Buy | $30.00 | N/A | Reiterates | a year ago |
Exelixis IncEXEL | 5 | Strong Buy | $60.00 | N/A | Upgrades | a year ago |
Blueprint Medicines CorpBPMC | 3 | Hold | $135.00 | N/A | Downgrades | a year ago |
Elevation Oncology IncELEV | 3 | Strong Buy | $5.00 | N/A | Reiterates | a year ago |
Adc Therapeutics SaADCT | 2 | Strong Buy | $8.00 | N/A | Maintains | 2 years ago |
Bicycle Therapeutics PLCBCYC | 2 | Hold | $15.00 | N/A | Reiterates | 2 years ago |
Faeth Therapeutics IncFTH | 2 | Strong Buy | $100.00 | N/A | Reiterates | 2 years ago |
Inovio Pharmaceuticals IncINO | 1 | Strong Buy | $20.00 | N/A | Initiates Coverage On | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.